Form D · Other Health Care
LABVANTAGE LX CORP
New York, NY · CIK 0001657178
Offering snapshot reported Nov 2, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250524
CONVERTIBLE DEBT TO EQUITY
Source: Form D, filed Nov 2, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vitaly Fargesen | Promoter |
| Igor Palatnik | Promoter |
| Mark Yushuvayev | Director, Executive |
| Josef Yushuvayev | Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
370 Lexington Avenue Suite 1511
New York, NY, 10017
New York, NY, 10017